Author: Margaret Moses Branch

FDA Warns Of Risks Associated With Transvaginal Mesh

Recently the FDA issued a transvaginal mesh warning concerning the use of the medical device (also known as pelvic mesh, pelvic sling, or bladder mesh) as a method to repair pelvic organ prolapse. The FDA warning stated that using transvaginal mesh to repair pelvic organ prolapse exposes patients to an “unnecessary risk” without providing any… read more

DePuy Hip Linked To Metal Poisoning

More and more claims concerning the troubled DePuy Hip continue to emerge. A recent article reveals that in addition to extreme pain from the faulty medical device, other symptoms related to metal poisoning occurred. According to one DePuy Hip patient – Tony Stauffer – discussed in the San Diego news, his hair started to fall… read more

DePuy Hip Recall Makes Some Experts Question FDA Medical Device Review Process

A recently released medical device study concludes that the FDA should “abandon” its present system for approving U.S. medical devices such as the DePuy Hip because it fails to ensure patient safety. Currently, the FDA employs a streamlined approach to approve medical device applications such as those for the beleaguered DePuy knee and hip parts… read more

Yaz Investigated For Increased Risk Of Blood Clots

Many types of birth control pills create risks of blood clots. However, new birth control research suggests that certain types of pills create an even higher risk of blood clots than others. Birth control pills that contain Drospirenone – such as Yaz, Yasmin, and Beyaz contain a two to three-time higher risk for developing blot… read more

Zimmer Introduces New Tool For Use In Defective Knee Revision Surgeries

Zimmer Holdings – maker of the defective Zimmer NexGen knee replacements – has recently announced that it has developed a complete set of Trabecular Metal material augmented shapes and cones to be used in knee revision surgeries. These new augments are intended to fill any size bone defects detected while performing surgery and supposed to… read more

Topamax May Alter Effectiveness Of Birth Control Pills

Recent reports indicate that in addition to problems such as cleft palates and cleft lip from taking Topamax, Topamax may cause oral contraceptives to lose their effectiveness. Topamax (topiramate) is a popular migraine and seizure medication that has been recently revised by the FDA as a “Class D” pregnancy drug – i.e. one where significant… read more

Topamax Recall After Reports Of Unusual Odors

Johnson & Johnson has issued a Topamax recall after receiving complaints about an unusual odor linked to a byproduct from a chemical used in treating wood. Sources believe the contamination may have occurred as a result of the way medication is shipped and stored. Topamax has recently come under fire after the FDA issued warnings… read more

Senate To Begin Investigation Of DePuy Hip Safety

This week the U.S Senate will begin its probe into medical device recalls and the connection between the massive DePuy Hip Replacement recall and the FDA’s role in “protecting patient safety as part of the medical device approval process.” The DePuy Hip was recalled after numerous reports of metal shards breaking off the hip replacement… read more

Zimmer NexGen Knee Recall Urged Due To Component Problems

Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that… read more

FDA Removes 500 Unapproved Prescription Drugs From The Market

The FDA has announced that it will be seeking to remove nearly 500 unapproved prescription drugs from the market. In a statement, the director of compliance at the Center for Drug Evaluation and Research notes that they “don’t know what’s in them, whether they work properly, or how they are made.” If believe you may… read more